A new GBP10 million Innovation and Knowledge Centre (IKC), that will boost the UK's ability to translate the emerging field of synthetic biology into application and provide a bridge between academia and industry was announced yesterday.
Researchers have developed a technique for the rapid and reliable distinction between strains that can cause chronic infections and those that cannot. Using infrared light and artificial intelligence, the scientists present a sophisticated method for the prediction of disease progression.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
Photosynthesis takes place in specialized membrane systems, made up of stacked disks linked together by unstacked planar leaflets. An LMU team has now identified a protein that tucks the membrane in at the edge of each stack.
In Bolivia, in the largest continuous salt desert in the world, researchers from the Polytechnic University of Catalonia have found a bacterium that stores large amounts of PHB, a prized polymer. This biodegradable plastic is used by the food and pharmaceutical industries, for example to produce nanospheres to transport antibiotics.
Genetic mutations aren't the only thing that can keep a protein called PTEN from doing its tumor-suppressing job. Johns Hopkins researchers have now discovered that four small chemical tags attached (reversibly) to the protein's tail can have the same effect, and they say their finding may offer a novel path for drug design to keep PTEN working.
Researchers from the National Environmental Engineering Research Institute in Nehru Marg, India have added another piece to the puzzle of how to synthetize an artificial nicotine receptor. One of the most long-lasting goals of biomedical science and technology is to design and synthesize efficient artificial receptors that would point to new avenues in the treatment of addiction.
Researchers at the London Centre of Nanotechnology and Universities of Bristol and Southampton have made a distinctive step towards the understanding of bacterial resistance to ribosome-targeting antibiotics.
A cellular control mechanism prevents the production of defective proteins in our cells. A team of researchers from Bern has now obtained valuable insights into this vital mechanism that could lead to new therapeutic approaches for genetic diseases.